lucentis

Generic: ranibizumab

Labeler: genentech, inc.
NDC Directory HUMAN PRESCRIPTION DRUG BLA Inactive Finished

Drug Facts

Product Profile

Brand Name lucentis
Generic Name ranibizumab
Labeler genentech, inc.
Dosage Form INJECTION, SOLUTION
Routes
INTRAVITREAL
Active Ingredients

ranibizumab 6 mg/mL

Manufacturer
Genentech, Inc.

Identifiers & Regulatory

Product NDC 50242-082
Product ID 50242-082_71a6df7b-906b-4de9-ad4f-200285958cdc
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category BLA
Application Number BLA125156
Listing Expiration 2026-12-31
Marketing Start 2012-08-10

Pharmacologic Class

Established (EPC)
vascular endothelial growth factor inhibitor [epc]
Mechanism of Action
vascular endothelial growth factor inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 50242082
Hyphenated Format 50242-082

Supplemental Identifiers

RxCUI
1864423 1864425 2045501 2045502
UNII
ZL1R02VT79
NUI
N0000193542 N0000193543

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name lucentis (source: ndc)
Generic Name ranibizumab (source: ndc)
Application Number BLA125156 (source: ndc)
Routes
INTRAVITREAL
source: ndc

Resolved Composition

Strengths
  • 6 mg/mL
source: ndc
Packaging
  • 1 SYRINGE, GLASS in 1 CARTON (50242-082-03) / .05 mL in 1 SYRINGE, GLASS
  • 1 SYRINGE, GLASS in 1 CARTON (50242-082-88) / .05 mL in 1 SYRINGE, GLASS
source: ndc

Packages (2)

Ingredients (1)

ranibizumab (6 mg/mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAVITREAL"], "spl_id": "71a6df7b-906b-4de9-ad4f-200285958cdc", "openfda": {"nui": ["N0000193542", "N0000193543"], "unii": ["ZL1R02VT79"], "rxcui": ["1864423", "1864425", "2045501", "2045502"], "spl_set_id": ["de4e66cc-ca05-4dc9-8262-e00e9b41c36d"], "pharm_class_epc": ["Vascular Endothelial Growth Factor Inhibitor [EPC]"], "pharm_class_moa": ["Vascular Endothelial Growth Factor Inhibitors [MoA]"], "manufacturer_name": ["Genentech, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 SYRINGE, GLASS in 1 CARTON (50242-082-03)  / .05 mL in 1 SYRINGE, GLASS", "package_ndc": "50242-082-03", "marketing_start_date": "20180320"}, {"sample": true, "description": "1 SYRINGE, GLASS in 1 CARTON (50242-082-88)  / .05 mL in 1 SYRINGE, GLASS", "package_ndc": "50242-082-88", "marketing_start_date": "20180320"}], "brand_name": "LUCENTIS", "product_id": "50242-082_71a6df7b-906b-4de9-ad4f-200285958cdc", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Vascular Endothelial Growth Factor Inhibitor [EPC]", "Vascular Endothelial Growth Factor Inhibitors [MoA]"], "product_ndc": "50242-082", "generic_name": "RANIBIZUMAB", "labeler_name": "Genentech, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "LUCENTIS", "active_ingredients": [{"name": "RANIBIZUMAB", "strength": "6 mg/mL"}], "application_number": "BLA125156", "marketing_category": "BLA", "marketing_start_date": "20120810", "listing_expiration_date": "20261231"}